Home > Boards > US OTC > Cannabis >

Kali Inc. (KALY)

KALY RSS Feed
Add KALY Price Alert      Hide Sticky   Hide Intro
Moderator: stockdarockk, On2_addict, rkrk, I know More, PhenixBleu, surfnnole
Search This Board: 
Last Post: 3/19/2019 3:37:07 PM - Followers: 377 - Board type: Free - Posts Today: 54


GOLDMAN SMALL CAP RESEARCH REPORT

OTC MARKETS CAVEAT EMPTOR FLAG REASON - ALSO NOTE THAT KALI HAS BEEN CURRENT IN ITS REPORTING SINCE DECEMBER 14, 2018

OTC MARKETS CAVEAT EMPTOR POLICY

 

       


Welcome to the Kali, Inc. Board!

USOTC:KALY


8300 Douglas Ave Suite 800, Dallas, TX 75225
214-210-0459


ir@kali-extracts.com

www.kali-extracts.com

OTC NEWS RELEASES


AUTHORIZED:  5,000,000,000           OUTSTANDING:   1,116,240,706          RESTRICTED:  255,174,312              UNRESTRICTED:  861,066,394              HELD AT DTC:  720,786,846

Baseline I/O is Q3 Report
09/30/2018:  846,240,706
12/14/2018: 1,018,240,706 (+172M)
1/16/2018:  1,116,240,706 (+98M)

TA Verified
LINK TO FINRA'S DAILY SHORT VOLUME REPORT (USE ORF SECTION)


 

Extraction Partnership - Canada Market Extraction Partnership US Cannabis Health - Joint Venture
KALY - NOUV PURA KALY - PURA - NOUV
NOUV has a cannabis cultivation business with operations
in the U.S. and Canada.  The two companies will work together
to product cannabis extracts utilizing KALY's patented cannabis
extraction process for the recreational marijuana market.
PURA and KALY plan to contract licensed extraction facilities
in Colorado and California to produce THC for PURA's THCSavor
products under KALY’s patented process and supervision. 

 
KALY has entered into a joint venture agreement with
Puration and Nouveau Pharmaceuticals to combine their
respective resources for the purpose of developing
partnerships with major pharmaceutical companies.

 
PATENTED CANNABIS EXTRACTION PROCESS

U.S. Patent No. 9,199,960 entitled “Method and Apparatus for Processing Herbaceous Plant Materials including the Cannabis Plant

Kali Inc announced the acquisition of NCM Biotech which is the developer and owner of a patented cannabis extraction process.  NCM Biotech’s current research and ongoing
pharmaceutical developments come with the acquisition. The acquired cannabis biotechnology intellectual properties will be contained within the new
Kali Cannabis Therapies
subsidiary where ongoing research and development will be conducted for the purposes of producing cannabis treatments for specific conditions.

“I don’t think any cannabis extractor has more credibility or experience than we do with our patented process and preclinical trial results,” said Frederick Ferri,
CEO of Kali-Extracts. “Hemp farmers will need CBD extraction services and can’t afford to risk their crop with an inexperienced or first-time extractor.  Our
franchise process will deploy trained extractors with a patented and proven process nationwide.” 


Kali-Extracts plans to begin marketing the CBD extraction franchise in February.

 

KALI'S NEW BUSINESS PLAN

With the patented intellectual property (IP), to include the existing and ongoing research and development acquired from NCM Biotech, Kali will now concentrate
on the development of pharmaceuticals to treat various illnesses, diseases and chronic pain as a symptom of various diagnoses.  Kali will also concentrate on the
development of health and wellness therapies.  The cannabis pharmaceuticals market is forecasted to reach
$50 billion in sales by 2029.  The cannabis concentrates
for wellness, edibles, and recreational markets is forecasted to reach
$8.5 billion in annual sales by 2022

Prior to the acquisition by Kali, NCM Biotech was engaged with a number of different universities on a number of separate research initiatives.  As an example, and as a preview of
an upcoming announcement, NCM has been involved in an ongoing study with a university in Kentucky on the use of a cannabis therapy derived from Kali’s patented extraction process
for the treatment of Chronic Obstructive Pulmonary Disease (COPD). A paper on the results of the study using Kali’s patented extraction process is anticipated to be published soon.

NCM Biotech's medical advisory team includes
John N. Gaitanis, MD., Director of Child Neurology at Tufts Medical Center/Floating Hospital for Children; 
Lloyd R. Saberski, M.D., Associate Professor of Anesthesiology and Chronic Pain Management, Yale University, and John McMichael, Ph.D., President & CEO Beech Tree Labs.

Preclinical Research Study Results on Therapy for Respiratory Disease (COPD and Asthma)


Hemp4mula Logo (PRNewsfoto/Kali, Inc.)

Kali-Extracts announced launching its own line of hemp-derived CBD infused candies and vapes under the brand name Hemp4mula. The company also announced initiating production on
Hemp4mula gum with a wholesale order anticipated immediately after the completion of the hemp-derived CBD infused gum production. Kali-Extracts expects to  produce hemp-derived
CBD infused mints and gummies shortly after completing production of the gum. Hemp4mula vapes are anticipated to be in production early next year.

 


LETTER TO SHAREHOLDERS FROM INCOMING CEO FREDERICK FERRI - NOVEMBER 27, 2018

Dear Kali Shareholders –

I’m delighted to be joining you in taking Kali in a new direction.  I’ve been working for years now in developing the science behind a cannabis extraction process in addition to working on applications for the
extracts from that process.  As you likely already know by now, the extraction process has been patented.  However, you are likely less familiar with the research that has been conducted with various extracts
derived from the patented process.  Over the coming months you will have the opportunity to learn a good deal about the research. You can expect to soon see the publication of research based on the
application of extracts from the patented process in the treatment of specific conditions and diseases.  In the meantime, I encourage you to visit the new Kali website my team has built to keep shareholders
up to date on our latest developments.  The website is brand new and a work in progress, so check back frequently.  In particular, please take time to review the section on Kali’s new business plan in
conjunction with the recent acquisition of NCM Biotech, the company I founded: 
https://www.kali-extracts.com/kaliextract-biz-plan

The announcement yesterday between Puration and Generex is very exciting for Kali.  Let me explain why.  First, you need to know that Puration is the only licensee of what is now Kali’s patented cannabis
extraction process.  Puration has licensed the patent for specific, non-pharmaceutical applications.  In conjunction with their license, Puration has been very successful in developing and marketing a CBD
infused bottled water called EVERx CBD Sports Water.  Second, you need to know that Puration and Kali have formed a joint venture company called US Cannabis Health for the purpose of developing and
marketing pharmaceutical applications and non-pharmaceutical wellness concentrates derived from Kali’s patented extraction process.  Now understanding the relationship between Puration and Kali, know
that the announcement yesterday about the agreement between Puration and Generex was part of a larger agreement executed between Generex and US Cannabis Health.  While Puration will be producing
the NuGenerex CBD HydroHealth High Alkaline Water, Kali will be developing custom CBD extracts for Puration to infuse into the NuGenerex CBD HydroHealth High Alkaline Water.

With the patented extraction process now under the Kali banner, we have already developed and tested a number of different extracts as therapies for symptoms of specific health issues.  We have accordingly
already initiated the process of filing for new patents in conjunction with our research.  With the Generex agreement announced yesterday, we will refine our existing research to specifically target
Generex’s purposes and correspondingly file additional patent applications on behalf of Kali, Puration, US Cannabis Health and Generex.


I anticipate that with my letter today, you now have a better understanding of why I am so excited for Kali and its shareholders about the announcement yesterday by Puration and Generex.  I think the Puration
and Generex shareholders should be equally excited.  I am thoroughly familiar with all of the current cannabis extraction science in the marketplace and I contend that our technology is a standout.  I am
confident the NuGenerex CBD HydroHealth High Alkaline Water will be a big success.  I am even more excited by what I believe this first step with Generex will lead to in regard to pharmaceutical applications
derived from Kali’s patented extract process.

Sincerely,
Frederick Ferri

 
DAILY WEEKLY
KALY KALY

 
KALY
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KALY News: KALY's Upcoming Annual Report Likely To Trigger $0.01 PPS Run To $0.10 09:00 AM
KALY News: KALY Initiates Phase Two Cannabis Extract COPD Treatment Study 03/18/2019 12:43:27 PM
KALY News: GDET On Verge Of BREAKOUT From $0.005 to $0.05 Pending Speculative Cannabis Announcement 03/12/2019 01:05:20 PM
KALY News: PURA - Puration Signs New CBD Beverage Distribution Orders With Even Bigger Orders Underway Fueling M&A Interest 03/07/2019 09:18:13 AM
KALY News: PURA - BUY Recommendation From American Bulls With Potential PPS Triple 03/06/2019 11:35:44 AM
News News Alert: KALY's Upcoming Annual Report Likely To Trigger $0.01 PPS Run To $0.10 03/19/2019 09:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#24127  Sticky Note Here is the link for the study that legendary_profit 02/06/19 12:40:17 PM
#19494  Sticky Note FDA Says CBD Products Remain Illegal Post-Farm Bill[ dnoto 12/31/18 09:59:18 AM
#25644   The push to .0120+ could occur by the GP65 03/19/19 03:37:07 PM
#25643   would be nice to get a real update rkrk 03/19/19 03:16:44 PM
#25642   Sounds good. Thanks for the update PRmaniac 03/19/19 03:01:37 PM
#25641   YES thank YOU. BDIY 03/19/19 02:57:06 PM
#25640   Laugh, its healthy for you. Billybob6925 03/19/19 02:54:20 PM
#25639   Yes sometimes I smile and sometimes I fight :-) BDIY 03/19/19 02:52:43 PM
#25637   I'm no one else but me sorry to Michael 14 03/19/19 02:38:01 PM
#25636   Ok thanks for the info BUT this is BDIY 03/19/19 02:35:57 PM
#25635   Lol Kaly. Billybob6925 03/19/19 02:29:34 PM
#25632   05/02/2013 application for provisional Michael 14 03/19/19 02:11:46 PM
#25630   THIS IS NOT CORRECT: ARE YOU SCARING THE BDIY 03/19/19 01:59:53 PM
#25629   My apologies yes they have patent. I was Michael 14 03/19/19 01:56:08 PM
#25628   SO YOU DON'T EVEN READ THE BOARD? BDIY 03/19/19 01:53:55 PM
#25627   SO THEY DON'T EVEN HAVE THE PATENT THEY PRmaniac 03/19/19 01:52:41 PM
#25626   A 30 second DD and here is the BDIY 03/19/19 01:49:12 PM
#25625   I've researched the provisional Michael 14 03/19/19 12:57:13 PM
#25624   This has hit .03 four times in the GP65 03/19/19 11:59:57 AM
#25623   Hmmmm..... Not an SEC registered company..... yet its IMACMAN 03/19/19 11:44:30 AM
#25622   We should see .0120-.0130+ very shortly (today or GP65 03/19/19 11:27:38 AM
#25620   Then it should distance itself from the scam IMACMAN 03/19/19 10:58:13 AM
#25619   This is not an SEC-registered business. Kali is PhenixBleu 03/19/19 10:56:07 AM
#25618   Good luck!..... eyes wide open...... i am not IMACMAN 03/19/19 10:51:48 AM
#25617   Annual comming, read last PR. Oh also,,, ".  It BottomTurn 03/19/19 10:50:02 AM
#25616   Except this has nothing to do with the CryptoRome 03/19/19 10:48:09 AM
#25615   Its comming off, very soon. Get in now BottomTurn 03/19/19 10:48:05 AM
#25614   Question..... is it “bashing”...... when the information and IMACMAN 03/19/19 10:43:25 AM
#25613   THE GOING IS GETTING GOOD HERE!!! THE LOG 03/19/19 10:42:32 AM
#25612   This worth accumulating right now at these levels? Wkboyd 03/19/19 10:33:06 AM
#25611   The Bashers didn’t like that third party news CryptoRome 03/19/19 10:29:03 AM
#25610   I didn't buy into that third-party promo. If PhenixBleu 03/19/19 10:19:34 AM
#25609   Geez...they've BEEN current since last December. The PhenixBleu 03/19/19 10:17:13 AM
#25608   Hey, WB, did you know news is comming? BottomTurn 03/19/19 10:05:40 AM
#25607   Ask them... Probually an ocean racer. BottomTurn 03/19/19 10:01:08 AM
#25606   Nope, and neither does kaly........ WBCTrader 03/19/19 09:59:32 AM
#25605   Well if you knew how to trade, you BottomTurn 03/19/19 09:53:21 AM
#25604   No huge profits for this POS. Peggy 03/19/19 09:50:08 AM
#25603   Looks like people are holding buying in dips. Tbizzle12 03/19/19 09:41:41 AM
#25601   Do you have any idea how complex testing BottomTurn 03/19/19 09:30:58 AM
#25600   KALY could drop 95% lower on the news. PRmaniac 03/19/19 09:27:49 AM
#25599   Beware of nextbigticker stock promoter for KALY PRmaniac 03/19/19 09:25:47 AM
#25598   KALY’s Upcoming Annual Report Likely To Trigger $0.01 rkrk 03/19/19 09:18:29 AM
#25597   Nice post. My sentiments exactly. JMC21 03/19/19 09:05:53 AM
#25596   IT WORKS! zig zag 03/19/19 08:21:18 AM
#25595   WHY!! A report on the first primate study SubPenny0001 03/19/19 08:09:34 AM
#25594   Thank you :-) BDIY 03/19/19 07:21:29 AM
#25593   quote rkrk BDIY 03/19/19 06:59:54 AM
#25592   Can’t buy it in Fedility... When are they Chingga 03/19/19 06:43:15 AM
#25591   No, lack of patients.. New businesses take time, BottomTurn 03/19/19 12:25:39 AM
#25590   Wow smartest thing u said on this board HORUS 03/18/19 11:36:38 PM
#25589   BUNCH OF BULLSHIT AS THE STOCK PRICE NEVER MOVES BootsandCoots 03/18/19 10:20:52 PM
PostSubject